These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9876213)

  • 1. Strategies that support declining cholinergic neurotransmission in Alzheimer's disease patients.
    Sirviö J
    Gerontology; 1999; 45 Suppl 1():3-14. PubMed ID: 9876213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cholinergic hypothesis of Alzheimer's disease: a review of progress.
    Francis PT; Palmer AM; Snape M; Wilcock GK
    J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):137-47. PubMed ID: 10071091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic strategies in the treatment of Alzheimer's disease.
    Davidson M; Stern RG; Bierer LM; Horvath TB; Zemishlani Z; Markofsky R; Mohs RC
    Acta Psychiatr Scand Suppl; 1991; 366():47-51. PubMed ID: 1897375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET studies and cholinergic therapy in Alzheimer's disease.
    Nordberg A
    Rev Neurol (Paris); 1999; 155 Suppl 4():S53-63. PubMed ID: 10637939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New therapeutic options in Alzheimer's disease].
    García-Ruiz Espiga PJ; Echeverría A; García-Torres A; Contreras A
    Rev Neurol; 2006 Apr 16-30; 42(8):478-81. PubMed ID: 16625510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reappraising neurotransmitter-based strategies.
    Möller HJ
    Eur Neuropsychopharmacol; 1999 Apr; 9 Suppl 2():S53-9. PubMed ID: 10332935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acetylcholinesterase inhibitors for treatment of Alzheimer's disease].
    Shinagawa S; Shigeta M
    Brain Nerve; 2014 May; 66(5):507-16. PubMed ID: 24807367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease.
    Levy ML; Cummings JL; Kahn-Rose R
    Gerontology; 1999; 45 Suppl 1():15-22. PubMed ID: 9876214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurotransmitters in Alzheimer's disease].
    Manzano-Palomo S; De la Morena-Vicente MA; Barquero MS
    Rev Neurol; 2006 Mar 16-31; 42(6):350-3. PubMed ID: 16575771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Alzheimer's disease: an evaluation of the cholinergic approach.
    Lemière J; Van Gool D; Dom R
    Acta Neurol Belg; 1999 Jun; 99(2):96-106. PubMed ID: 10427352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: an update.
    Weinstock M
    Neurodegeneration; 1995 Dec; 4(4):349-56. PubMed ID: 8846227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticholinesterases in the treatment of Alzheimer's disease].
    Gandía L; Alvarez RM; Hernández-Guijo JM; González-Rubio JM; de Pascual R; Rojo J; Tapia L
    Rev Neurol; 2006 Apr 16-30; 42(8):471-7. PubMed ID: 16625509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical pathology and treatment strategies in Alzheimer's disease: emphasis on the cholinergic system.
    Winblad B; Messamore E; O'Neill C; Cowburn R
    Acta Neurol Scand Suppl; 1993; 149():4-6. PubMed ID: 8128837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profile of donepezil in the treatment of Alzheimer's disease.
    Doody RS
    Gerontology; 1999; 45 Suppl 1():23-32. PubMed ID: 9876215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
    Wenk GL
    J Clin Psychiatry; 2006; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cholinesterase inhibitors on attention.
    Pepeu G; Giovannini MG; Bracco L
    Chem Biol Interact; 2013 Mar; 203(1):361-4. PubMed ID: 23047023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents.
    Lahiri DK; Rogers JT; Greig NH; Sambamurti K
    Curr Pharm Des; 2004; 10(25):3111-9. PubMed ID: 15544501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do acetylcholinesterase inhibitors boost synaptic scaling in Alzheimer's disease?
    Small DH
    Trends Neurosci; 2004 May; 27(5):245-9. PubMed ID: 15111005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tacrine].
    Dávila C; Viteri C; de Castro P
    Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donepezil induces a cholinergic sprouting in basocortical degeneration.
    Ginestet L; Ferrario JE; Raisman-Vozari R; Hirsch EC; Debeir T
    J Neurochem; 2007 Jul; 102(2):434-40. PubMed ID: 17394553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.